Cargando…

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin

PURPOSE: To evaluate metformin’s benefit on the incidence and survival of hepatocellular carcinoma (HCC) in cirrhosis with type 2 diabetes mellitus (T2DM) patients. PATIENTS AND METHODS: We conducted a retrospective study from 2006 to 2019. The patients were assigned to metformin exposure if they ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tangjarusritaratorn, Thanida, Tangjittipokin, Watip, Kunavisarut, Tada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043797/ https://www.ncbi.nlm.nih.gov/pubmed/33859487 http://dx.doi.org/10.2147/DMSO.S295753

Ejemplares similares

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
por: Kunavisarut, Tada, et al.
Publicado: (2019)

Prognostic Analysis of Postoperative Survival for Ruptured Hepatocellular Carcinoma with or without Cirrhosis
por: Xia, Feng, et al.
Publicado: (2022)

Detection of CAPN10 copy number variation in Thai patients with type 2 diabetes by denaturing high performance liquid chromatography and real-time quantitative polymerase chain reaction
por: Plengvidhya, Nattachet, et al.
Publicado: (2015)

HNF1A mutation in a Thai patient with maturity-onset diabetes of the young: A case report
por: Plengvidhya, Nattachet, et al.
Publicado: (2019)

Incidence of hepatocellular carcinoma in nonalcoholic fatty liver disease without cirrhosis or advanced liver fibrosis
por: Behari, Jaideep, et al.
Publicado: (2023)

Prevalence and Characteristics of Prediabetes and Metabolic Syndrome in Seemingly Healthy Persons at a Health Check-Up Clinic
por: Tangjittipokin, Watip, et al.
Publicado: (2022)

Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101
por: He, Chao-Bin, et al.
Publicado: (2017)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population
por: Plengvidhya, Nattachet, et al.
Publicado: (2018)

Changes in Arterioportal Shunts in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis Who Were Treated with Chemoembolization Followed by Radiotherapy
por: Oh, Dongryul, et al.
Publicado: (2015)

COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL
por: de FREITAS, Alexandre Coutinho Teixeira, et al.
Publicado: (2016)

The Variants in ADIPOQ are Associated with Maternal Circulating Adipokine Profile in Gestational Diabetes Mellitus
por: Tangjittipokin, Watip, et al.
Publicado: (2023)

Thoughtful Response on “The Variants in ADIPOQ are Associated with Maternal Circulating Adipokine Profile in Gestational Diabetes Mellitus” [Response to Letter]
por: Tangjittipokin, Watip, et al.
Publicado: (2023)

Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma With and Without Cirrhosis
por: Chebib, Ivan, et al.
Publicado: (2007)

Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases
por: Wang, Chen‐Pin, et al.
Publicado: (2019)

Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol
por: Yamada, Masayoshi, et al.
Publicado: (2011)

Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience
por: Shin, Jongbeom, et al.
Publicado: (2019)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Factors Affecting Therapeutic Effects in 17 Patients with Advanced Hepatocellular Carcinoma Who Were Treated with Sorafenib for More than 12 Months
por: Katayama, Kazuhiro, et al.
Publicado: (2018)

Incidence, Mortality, and Predictive Factors of Hepatocellular Carcinoma in Primary Biliary Cirrhosis
por: Hosonuma, Kenichi, et al.
Publicado: (2013)

Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2016)

Hepatocellular carcinoma in patients with B and C virus hepatitis without cirrhosis
por: Carvalho, Kellyane Santana Dias, et al.
Publicado: (2017)

Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
por: Currie, Craig J., et al.
Publicado: (2012)

Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma.
por: Johnson, P. J., et al.
Publicado: (1981)

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2021)

Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis
por: Lee, Chern-Horng, et al.
Publicado: (2023)

Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.
por: Ding, S. F., et al.
Publicado: (1991)

Correction: Who Treats Patients with Diabetes and Compensated Cirrhosis
por: Liu, Tsai-Ling, et al.
Publicado: (2018)

IDO and intra‐tumoral neutrophils were independent prognostic factors for overall survival for hepatocellular carcinoma
por: Wang, Yan, et al.
Publicado: (2019)

Clinical Characteristics, Glycemic Control, and Microvascular Complications Compared Between Young-Onset Type 1 and Type 2 Diabetes Patients at Siriraj Hospital – A Tertiary Referral Center
por: Preechasuk, Lukana, et al.
Publicado: (2022)

Cluster analysis of Thai patients with newly diagnosed type 2 diabetes mellitus to predict disease progression and treatment outcomes : A prospective cohort study
por: Preechasuk, Lukana, et al.
Publicado: (2022)

Efficacy of Radiofrequency Ablation of Hepatocellular Carcinoma Associated with Chronic Liver Disease without Cirrhosis
por: Salmi, Andrea, et al.
Publicado: (2008)

Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West
por: Yen, Yi-Hao, et al.
Publicado: (2021)

Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis
por: Kim, Jong Man, et al.
Publicado: (2022)

Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review
por: Altshuler, Ellery, et al.
Publicado: (2022)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Platelet lymphocyte ratio and sarcopenia were associated with survival after hepatocellular carcinoma undergoing curative resection
por: Feng, Xuping, et al.
Publicado: (2022)

Incidence and Clinical Features of Hepatitis C Virus-associated Hepatocellular Carcinoma Patients without Liver Cirrhosis in Hepatitis B Virus-endemic Area
por: Shin, Jongbeom, et al.
Publicado: (2021)

Survival at 30 days in elderly patients with hip fracture surgery who were exposed to hypothermia: Survival study
por: Charles-Lozoya, Sergio, et al.
Publicado: (2021)

Postsurgical rehabilitation for adults with low back pain with or without radiculopathy who were treated surgically: protocol for a mixed studies systematic review
por: Cancelliere, Carol, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_39mnp7dep2ikalb9n305b5rod9